Browsing Nord Open Research Archive by Author "Hilmarsdòttir, Bylgja"
Now showing items 1-4 of 4
-
Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
Karvelsson, Sigurdur; Wang, Qiong; Hilmarsdòttir, Bylgja; Sigurdsson, Arnar; Moestue, Siver Andreas; Mælandsmo, Gunhild Mari; Halldórsson, Skarphédinn; Gudmundsson, Steinn; Rolfsson, Ottar (Peer reviewed; Journal article, 2021) -
Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen
Barkovskaya, Anna; Goodwin, Craig M.; Seip, Kotryna; Hilmarsdòttir, Bylgja; Pettersen, Solveig; Stalnecker, Clint; Engebraaten, Olav; Briem, Eirikur; Der, Channing J.; Moestue, Siver Andreas; Guðjónsson, Þórarinn; Mælandsmo, Gunhild Mari; Prasmickaite, Lina (Peer reviewed; Journal article, 2021) -
Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer
Grinde, Maria Tunset; Hilmarsdòttir, Bylgja; Tunset, Hanna Maja; Henriksen, Ida Marie; Kim, Jana; Haugen, Mads Haugland; Rye, Morten Beck; Mælandsmo, Gunhild Mari; Moestue, Siver Andreas (Journal article; Peer reviewed, 2019) -
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
Barkovskaya, Anna; Seip, Kotryna; Hilmarsdòttir, Bylgja; Mælandsmo, Gunhild Mari; Moestue, Siver Andreas; Itkonen, Harri M. (Journal article; Peer reviewed, 2019)